AdvaMed Slams Risk-Based Class IIIs Plan As Opening Door to Unnecessary PMAs

Devices & Diagnostics Letter
Devicemakers are asking the FDA to retain the current classification scheme for Class III devices, saying a proposal to establish risk-based categories would require PMAs for many more devices than currently undergo full premarket approval.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00